Legal status · United States
Is GIP legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. GIP is not an approved medicine in the United States; its classification is "Not a drug; endogenous hormone and research infusion peptide". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile.
GIP in the United States at a glance
| Classification | Not a drug; endogenous hormone and research infusion peptide |
|---|---|
| Note | Drugs acting at its receptor are approved. The hormone itself is not a therapeutic. |
| FDA approval status | Not an approved drug and not in clinical use as a therapeutic. Drugs acting at its receptor are approved, including tirzepatide. |
| Human studies cited | 6 of 7 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the GIP profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing GIP is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What GIP is
One of your two incretin hormones, and the parent ligand of every dual and triple agonist on this site. Both blocking it and activating it produce weight loss in humans, which nobody has resolved.
GIP is one of the two mammalian incretins. It is released by K cells in the upper small intestine when you eat and it amplifies the insulin your pancreas puts out in response to glucose.
Mechanism: Binds GIPR, a class B1 secretin-family G protein-coupled receptor that is canonically Gs-coupled and raises cAMP. In the pancreatic beta cell that potentiates glucose-stimulated insulin secretion, which is glucose-dependent, so GIP does not drive insulin release when glucose is normal.
Regulatory history: Not an approved drug and not in clinical use as a therapeutic. Drugs acting at its receptor are approved, including tirzepatide.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for GIP at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
GIP in other countries
Frequently asked questions
Is GIP legal in the United States?
No. GIP is not an approved medicine in the United States; its classification is "Not a drug; endogenous hormone and research infusion peptide". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile. Note: Drugs acting at its receptor are approved. The hormone itself is not a therapeutic.
Can I buy GIP in the United States?
No approved product exists to buy. In the United States GIP is classified as "Not a drug; endogenous hormone and research infusion peptide", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Drugs acting at its receptor are approved. The hormone itself is not a therapeutic.
Is GIP FDA approved?
No. FDA status: Not an approved drug and not in clinical use as a therapeutic. Drugs acting at its receptor are approved, including tirzepatide.. Current US classification: "Not a drug; endogenous hormone and research infusion peptide". On the evidence, 6 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for GIP live on its compound profile.
GIP profileThis page is general information about the regulatory status of GIP in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.